Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
EnQuest plc is an independent United Kingdom-based petroleum exploration and production company focused on the extraction and development of hydrocarbons, primarily in the UK North Sea and Malaysia. Formed in 2010 through the demerger of assets from Petrofac and Lundin Petroleum, it operates maturing and underdeveloped oil fields, offering organic growth opportunities in upstream, midstream, and decommissioning activities. Key assets include the Magnus, Kraken, Golden Eagle, Scolty/Crathes, Greater Kittiwake Area, Alba, and PM8/Seligi projects, with full ownership in fields like Heather and Magnus, and significant stakes in others such as Broom (63%) and West Don (44.95%). As an energy transition company, EnQuest emphasizes energy security and decarbonisation, notably transforming the Sullom Voe Terminal in Shetland into a leading European energy hub, developing the Bressay heavy oil field alongside Bentley, and advancing new stabilisation facilities. Headquartered in London with around 670 employees, EnQuest generates most revenue from the North Sea, playing a vital role in sustaining UK oil and gas production while exploring new energy prospects.
£0.23
+£0.01 (+5.68%)
EOD Jul 3, 2026
23.54% operating margin is above average. ROIC at 8.36%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue declined 5.3% YoY. Margins deteriorated 8.7pp alongside, both lines moving the wrong way.
At 311x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 28% versus the prior year, cash generation momentum has weakened.
310.5x earnings, 3.1x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$1.12B
▼ -5.3% YoY
Net Income (TTM)
$2M
▼ -98.3% YoY
Op. Margin
23.54%
▼ -8.7pp YoY
ROIC
8.36%
▼ -5.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$183M
▼ -28.0% YoY
Op. Cash Flow (TTM)
$287M
▼ -0.5% YoY
Net Debt
$814M
Cash & Equiv.
$266M
3Y CAGR: -15.5%
3Y CAGR: -39.2%
Continue Research
At a P/E of 310.5 and a price-to-free-cash-flow of 3.1, EnQuest (ENQ.XLON) trades below a two-stage DCF intrinsic value of about $1.27 per share, so at $0.23 the stock looks undervalued (447.1% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, EnQuest scores 29/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 2.6%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $1.27 per share for ENQ.XLON, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $0.95. At today's $0.23, that puts the stock about 447.1% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
EnQuest scores 29 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 23.5% operating margin and a 8.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, EnQuest pays a regular dividend of about $0.01 per share per year (typically in quarterly installments), a yield of roughly 2.6% at the current price. That is a payout ratio of about 979.5% of earnings, so the dividend is stretched at this level. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For ENQ.XLON's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. ENQ.XLON currently trades below its estimated intrinsic value and scores 29/100 on quality (lower-quality). It also yields about 2.6%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.